Near-Infrared Fluorescent and Magnetic Resonance Dual-Imaging
Coacervate Nanoprobes for Trypsin Mapping and Targeted Payload Delivery
of Malignant Tumors
Version 2 2020-04-06, 17:04Version 2 2020-04-06, 17:04
Version 1 2020-04-02, 22:03Version 1 2020-04-02, 22:03
journal contribution
posted on 2020-04-06, 17:04authored byHeze Guo, Sheng Song, Tingting Dai, Kang Sun, Guangdong Zhou, Mei Li, Stephen Mann, Hongjing Dou
Trypsin-responsive
near-infrared fluorescent (NIRF) and magnetic
resonance (MR) dual-imaging composite nanoparticle/polypeptide coacervate
nanoprobes with tunable sizes, have been constructed herein via electrostatic
interaction-induced self-assembly. Considering the requirements of
in vivo metabolism on nanoparticle size, three coacervate nanoprobes
with diameters of around 100, 200, and 300 nm were fabricated with
a polydispersity of around 0.2. These coacervate nanoprobes consist
of Fe3O4 magnetic nanoparticles surface-decorated
with poly acrylic acid and Cy5.5-modified poly-l-lysine (PLL-g-Cy5.5) serving as MR imaging and trypsin-responsive substrate/NIRF
agents, respectively. The notable fluorescence signal from PLL-g-Cy5.5 is self-quenched due to the short distances between
the fluorescent Cy5.5 molecules after construction of the coacervate
nanoprobes. Remarkably, coacervate nanoprobes with a diameter of
around 100 nm are selectively disintegrated into fragmented segments
upon the hydrolysis of PLL by trypsin, resulting in an 18-fold amplification
of the NIRF intensity in comparison with the self-assembled coacervate
nanoprobes in the quenched state. Moreover, the MR imaging enhancement
is also related to the disintegration of the coacervate nanoprobes.
Cellular experiments and in vivo studies demonstrate that the coacervate
nanoprobes exhibit remarkable trypsin-sensitive NIRF and MR dual-imaging
capabilities and thus have excellent potential to serve as dual-imaging
nanoprobes for the efficient mapping of malignant tumors in which
trypsin is often overexpressed. In consideration of their excellent
capability to enrich charged molecules, the coacervate nanoprobes
provide a conceptually novel and promising platform toward in vivo
trypsin mapping and controlled delivery of targeted payloads.